Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
AstraZeneca
Citi
Chubb
Federal Trade Commission
Daiichi Sankyo

Generated: March 26, 2019

DrugPatentWatch Database Preview

Wes Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for WES PHARMA INC, and what generic and branded alternatives to WES PHARMA INC drugs are available?

WES PHARMA INC has six approved drugs.



Summary for Wes Pharma Inc
US Patents:0
Tradenames:4
Ingredients:4
NDAs:6

Drugs and US Patents for Wes Pharma Inc

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wes Pharma Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 210211-001 Oct 30, 2017 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Wes Pharma Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride SOLUTION;ORAL 210139-001 Oct 3, 2018 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Wes Pharma Inc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 207510-003 Mar 21, 2018 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Wes Pharma Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 210211-002 Oct 30, 2017 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Wes Pharma Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 210211-003 Oct 30, 2017 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Wes Pharma Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride SOLUTION;ORAL 209897-001 Sep 6, 2017 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Wes Pharma Inc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 207510-002 Mar 21, 2018 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Chubb
Moodys
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: